title: Leptin and neuropeptide Y (NPY) modulate nitric oxide synthase: further evidence for a role of nitric oxide in feeding.
abstract: Recent studies have suggested a role for nitric oxide in the regulation of food intake. Neuropeptide Y (NPY) is one of the most potent orexigenic agents. Chronic administration of leptin decreases food intake. This study examined the effects of NPY and leptin on nitric oxide synthase (NOS) in the hypothalamus. Previously it has been demonstrated that obese (ob/ob) mice have elevated NOS levels in the hypothalamus. In this study we demonstrated that the administration of leptin (6 microg/day) subcutaneously (SC) for 3 days decreased body weight (P < 0.001) and food intake P < 0.001) in obese (ob/ob) mice as expected. In addition, leptin decreased NOS in the hypothalamus nu 37% (P < 0.01) and in brown adipose tissue by 69% (P < 0.01) but not in white adipose tissue. NPY was administered intracerebroventricularly to CD-1 mice at doses of 0.25 and 0.50 microg. Mice were sacrificed 15 min after injection and NOS was measured in their hypothalami. NPY at the lower dose increased NOS in the hypothalamus by 147%. These results, taken together, with previously published studies support the concept that nitric oxide may play a role as a mediator of the effects of NPY and leptin on food intake. The alterations of NOS in brown adipose tissue following leptin administration could result in changes in blood flow or metabolism in the brown fat.
authors.affiliation: Geriatric Research, Education and Clinical Center, VA Medical Center, St. Louis, MO 63125, USA. morley@slu.edu
authors.forename: J E
authors.initials: JE
authors.lastname: Morley
authors.forename: M M
authors.initials: MM
authors.lastname: Alshaher
authors.forename: S A
authors.initials: SA
authors.lastname: Farr
authors.forename: J F
authors.initials: JF
authors.lastname: Flood
authors.forename: V B
authors.initials: VB
authors.lastname: Kumar
mesh_terms: D000273:Adipose Tissue / Q000201:enzymology; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D004435:Eating / Q000187:drug effects*; D007031:Hypothalamus / Q000201:enzymology*; D007276:Injections, Intraventricular; D007279:Injections, Subcutaneous; D020738:Leptin / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008820:Mice, Obese; D009478:Neuropeptide Y / Q000494:pharmacology*; D019001:Nitric Oxide Synthase / Q000032:analysis*
chemical_list: D020738:Leptin; D009478:Neuropeptide Y; D019001:Nitric Oxide Synthase